Rapid Itch Relief Seen with Nemolizumab - Top_Thought_Leaders - MDSpire

Rapid Itch Relief Seen with Nemolizumab

Researchers examined early itch and sleep outcomes with interleukin-31 pathway inhibition in atopic dermatitis and prurigo nodularis in phase 3 trial analyses.

  • By

  • Kathryn Wighton

  • January 8, 2026

  • 3 min

Share

Top Thought Leaders in Pathology

Brief introduction explaining scope and methodology.

Original Source(s)

Rapid Itch Relief Seen with Nemolizumab

  • by Kathryn Wighton

  • January 8, 2026

Related Content

Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial

Lymphocyte transformation test in pediatric drug hypersensitivity: case series report from a tertiary care hospital

AI Discharge Summaries Show Low Harm Risk

Most reviewed summaries were rated as posing no harm risk, although omissions remained common.